Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Science
Sarah Marsh and Guardian readers

Have you been affected by the misuse of Pregabalin in the UK?

pile of tablets
We want to hear from those who work in addiction services as well as those who know people who have taken Pregabalin. Photograph: Alamy Stock Photo

A growing number of deaths have been linked to the misuse of Pregabalin, a drug used to treat pain, anxiety and epilepsy. In 2012 there were four deaths linked to it and last year this rose to a 111.

It comes after claims that the drug has flooded the black market and is being sold illegally to addicts who mix it with other drugs, such as heroin. This can increase the risk of heart failure.

The government is about to start a consultation on pregabalin control, which could result in it being categorised as a Class C drug. Last year a letter from the Advisory Council on the Misuse of Drugs sent to the government discussed the potential harms associated with the misuse of the drug.

Share your stories

We want to hear from those who work in addiction services as well as those who have been affected by these drugs or know people who have become addicted. What are the dangers? Has there been a rise in n the illicit use of pregabalin and gabapentin? Should the drug be a class C controlled substance or are there other solutions? Share your stories. We will use some responses in our reporting.

You can share your experiences by filling in the form below, anonymously if you wish. Your responses are secure as the form is encrypted and only the Guardian has access to your contributions. We’ll feature some of your responses in our reporting.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.